---
title: "GulnurGV-онлайн платформа поддержки грудного вскармливания · emrr"
url: https://emrr.uz/gulnurgv
language: en
updated: 2026-11-18T10:19:18Z
source: emrr (https://emrr.uz)
---

# GulnurGV-онлайн платформа поддержки грудного вскармливания

[gulnurgv.kz](https://gulnurgv.kz/)

- **Industry**: HealthTech & MedTech
- **Based in**: Aqtobe, Kazakhstan

## Verified revenue: not connected yet

Is GulnurGV-онлайн платформа поддержки грудного вскармливания yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

[Claim it if it’s yours](https://panel.emrr.uz/reserve/gulnurgv)

## About

Up to 60% of women in the CIS face difficulties in breastfeeding (lack of milk, pain, stress, child's refusal to breastfeed), which leads to early transition to mixed feeding and a decrease in the quality of family life. GulNUR-GV is a mobile assistant application for mothers that combines: relaxation support using a unique methodology (1000+ successful cases), online consultations with experts, a knowledge library (articles, videos, FAQs), feeding and baby weight trackers, as well as communities for mothers. Uniqueness: the author's method of relaxation without analogues in the CIS, confirmed by the founder's expertise (7+ years of practice, cooperation with the regional healthcare and NGOs). Social effect: reducing family expenses and strengthening children's health. Monetization: subscription, premium access, courses, partner programs. Status: acquiring site, online courses, social community. Plans: MVP (tracking, library, chat), testing, scaling in the CIS, integration with telemedicine.

## Funding

- **Stage**: Idea

## Pitch deck

The founders’ own deck, for people signed in to emrr.

Profile data from startupbase.uz.

Updated 18 November 2026

[This page in Markdown](https://emrr.uz/gulnurgv.md)

[Get your verified page](https://emrr.uz/): Connect Stripe, the App Store or Google Play in two minutes and get a page like this one. emrr reads every figure itself, so investors don’t have to take your word for it. Free while MRR is under $1,000.
